European and American Guidelines for Multiple Sclerosis Treatment
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2018/10/12
-
Journal
-
Indian UGC (journal)
-
Refrences13
-
Citations41
-
Angelo Ghezzi
Cite
Ghezzi, Angelo. “European and American Guidelines for Multiple Sclerosis Treatment”. Neurology and Therapy, vol. 7, no. 2, 2018, pp. 189-94, https://doi.org/10.1007/s40120-018-0112-1.
Ghezzi, A. (2018). European and American Guidelines for Multiple Sclerosis Treatment. Neurology and Therapy, 7(2), 189-194. https://doi.org/10.1007/s40120-018-0112-1
Ghezzi A. European and American Guidelines for Multiple Sclerosis Treatment. Neurology and Therapy. 2018;7(2):189-94.
Journal Categories
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
Medicine
Medicine (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis | Multiple Sclerosis Journal |
| 422 | 2018 |
| Design and implementation of population-based specialty care programs | American Journal of Health-System Pharmacy |
| 4 | 2017 |
The importance of a multi-disciplinary perspective and patient activation programmes in MS management | Multiple Sclerosis Journal |
| 39 | 2016 |
| 10.1212/WNL.0000000000005345 | Neurology |
| 2018 | |
| 10.1212/WNL.0000000000005347 | Neurology |
| 2018 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system 7
is the most frequently represented among the references in this article. It primarily includes studies from Neurology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Association of multiple sclerosis with stroke: A comprehensive review | Health Science Reports |
| 2024 | |
| A comparison of clinical, utilization, and cost outcomes between oral treatments for multiple sclerosis | Journal of Managed Care & Specialty Pharmacy |
| 2024 | |
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register | Neurological Sciences |
| 1 | 2023 |
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives | Clinical and Experimental Medicine |
| 3 | 2023 |
| Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases | Advanced Drug Delivery Reviews |
| 2023 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system 14
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled An update on the safety of treating relapsing-remitting multiple sclerosis and was published in 2019. The most recent citation comes from a 2024 study titled A comparison of clinical, utilization, and cost outcomes between oral treatments for multiple sclerosis. This article reached its peak citation in 2023, with 16 citations. It has been cited in 31 different journals, 29% of which are open access. Among related journals, the Multiple Sclerosis and Related Disorders cited this research the most, with 6 citations. The chart below illustrates the annual citation trends for this article.